Prismaflex HF medical device sets recalled for instructional mistranslation
Baxter Healthcare recalls Prismaflex HF Set devices due to a mistranslation in Estonian language instructions. The mistranslation contains contradictory information about patient body weight restrictions.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II labeling defect involving a mistranslation in device instructions. No illnesses, injuries, or deaths have been reported. The issue is a correctable instructional error, though it affects safety-critical weight restriction information.
Plain-English summary
Baxter Healthcare Corporation is recalling 328,300 Prismaflex HF Set devices (models HF1000 and HF1400) distributed nationwide in the United States. These devices are used to provide continuous fluid management and renal replacement therapies.
The recall addresses a mistranslation in the Estonian language text within the Instructions for Use (IFU). The mistranslated text contains contradictory information related to patient body weight restrictions, which are critical safety parameters for proper device use.
Healthcare facilities and clinicians currently using these devices should review the updated instructions from Baxter Healthcare. Corrected documentation clarifies the intended weight restriction guidelines to ensure safe patient treatment.
The recalled product
- Product
- Prismaflex HF Set: HF1000 (product code 107140), HF1400 (product code 107142). For use in providing continuous fluid management and renal replacement therapies.
- Manufacturer
- Baxter Healthcare Corporation
- Affected units
- 328,300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- UDI 07332414069254 (product code 107140)
- 07332414069315 (product code 107142)
- All Lot Codes
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Baxter Healthcare Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- HighBaxter Recalls Likorall Overhead Lifts Due to Motor Shaft Breakage Risk
FDA (Devices) · 2026-10-21
- ModerateBaxter Recalls Two VOLARA Systems Due to Potential Flow Rate Inaccuracy
FDA (Devices) · 2026-09-30
- ModerateBaxter PRO+ 36-inch Mattress Recalled for UDI Labeling Error
FDA (Devices) · 2026-09-30
- ModerateBaxter PRO+ Mattress Recalled for UDI Labeling Error
FDA (Devices) · 2026-09-30
- ModerateBaxter Recalls PRO+ MRS Mattress Due to UDI Labeling Error
FDA (Devices) · 2026-09-30
Similar recalls
- HighBaxter Recalls Prismaflex Control Units Due to Software and Usage Issues
FDA (Devices) · 2018-04-11
- ModerateBaxter Recalls Prismaflex Systems for Pump Module Electronics Failure
FDA (Devices) · 2018-05-30
- ModerateBaxter Recalls Prismaflex Control Units for Firmware Update
FDA (Devices) · 2018-05-30
- ModerateBaxter Prismaflex 5.10 US Control Units Recalled for Firmware Update
FDA (Devices) · 2018-05-30
- ModerateBaxter Recalls Prismaflex 7.20 US Control Units for Firmware Update
FDA (Devices) · 2018-05-30
- ModerateBaxter Recalls Prismaflex Control Units Due to Tubing Performance Variability
FDA (Devices) · 2021-03-31